Research Findings

A comprehensive review indicates that children exposed to antipsychotics in the womb face an increased risk of ADHD and developmental delays.

In adolescent depression treatment, those who received a placebo but thought they received Prozac improved more than those who received the drug and knew it.

In this new study, exposure to maternal anxiety in utero also harmed child development.

A new study in Frontiers of Pharmacology finds that antidepressant use during pregnancy is linked to reduced motor skills in children at 2 years...

Mark Horowitz and David Taylor provide advice on how to tell the difference between antidepressant withdrawal and depression relapse.

Researchers found that rats born to mothers given the antidepressant Prozac during pregnancy or breastfeeding exhibited varied behavioral and developmental effects, with implications for the understanding of antidepressant impacts during human pregnancies.

When comparing kids with the same symptoms who were either diagnosed with ADHD or not, those who received the diagnosis had worse outcomes.

Leading ADHD researchers outline four mistakes that turned ADHD from a description of behavior into a medical disease.

Response and remission rates were the same in the drug versus placebo groups, and Lexapro increased suicidality sixfold.

Risk of depression increased when children were taking methylphenidate for ADHD, but once they stopped taking the drug, depression risk dropped to normal levels.

Researchers find that SSRIs increase suicide attempts up to age 24, and have no preventative effect at any age, even for those at high risk of suicide.

A study conducted on college-aged students finds strong correlations between biomedical characterizations of mental illness, pharmaceutical treatment, and social stigma.

A new study finds that newborn babies experience antidepressant withdrawal after birth if their mothers take SSRIs when pregnant.

Throughout the past two decades, studies have warned of increased suicide rates in those taking antidepressants, especially in children and adolescents. Researchers also documented...

Bias and financial conflicts in antidepressant trials “contribute to systematic underestimation of risk in the published literature.”

Neuroscience researchers find no differences in brain connectivity between children with diagnoses of autism, ADHD, and those with no diagnoses.

“Efforts to improve learning in children with ADHD should focus on obtaining effective academic instruction rather than stimulant medication.”

Noted antidepressant researcher, Michael Hengartner, summarizes the latest research on the use of antidepressants in children and adolescents.

Reduced brain volumes due to SSRI exposure in pregnancy was not explained by maternal depression alone.

Researchers discuss the evidence that antipsychotic medications may cause brain atrophy in children, whose brains are still developing.

A new study explores feelings of belongingness as a protective factor for childhood trauma and adult mental health outcomes.

A clinical trial finds Prozac no better than placebo for improving repetitive behaviors.

Medical researchers present evidence that ADHD is overdiagnosed in children and teens, which can lead to significant harm.

Depression, serious psychological distress, and suicide attempts have risen substantially since the early 2000s among young adults – what’s changed?

A new special issue brings together articles exploring the harmful effects of simultaneous multiple medication use.